TUESDAY, March 29, 2022 (HealthDay News) — Despite months of intense lobbying by patient advocates, federal health officials on Monday posted a largely negative review of an experimental drug for the devastating illness known as amyotrophic lateral sclerosis (ALS). In an analysis of Amylyx Pharmaceuticals’ drug, known for now onlyContinue Reading

TUESDAY, March 29, 2022 (HealthDay News) — An experimental cream-based gene therapy may soon become the first U.S. government-approved means for treating a rare and devastating skin disease that produces “butterfly children.” Patients with recessive dystrophic epidermolysis bullosa (EB) are called butterfly children “because their skin is as fragile asContinue Reading

Birth defects rise in babies born to men who took diabetes drug. Infants of men taking the common drug metformin may have a slightly increased risk, new Danish research shows. Read more FDA review gives thumbs down to new ALS drug. Despite months of intense lobbying by patient advocates, federalContinue Reading